Pilot Study of Virtual Reality to Treat Abdominal Pain in Adults with Crohns Disease Without Active Inflammation

What this Trial Is About

This research investigates whether virtual reality VR can improve abdominal pain and related quality of life issues in adults with Crohns disease CD who do not show signs of active inflammation. It focuses on patients aged 18 to 70 years who experience abdominal pain at least weekly despite normal inflammation markers. The study is a pilot trial assessing the safety, tolerability, and effectiveness of VR therapy for this condition. Participants will use a VR headset daily for at least 30 minutes over an 8-week period, with the freedom to use it longer if desired. Before starting VR treatment, there is a two-week pre-screening phase involving symptom questionnaires. Weekly phone calls will support and monitor participants during the VR treatment phase. During the study, demographic and medical information will be collected, including age, sex, race, medications, and other health conditions. Researchers will assess improvement in abdominal pain over 10 weeks as the primary outcome. This includes monitoring symptoms through questionnaires and weekly calls to understand how VR therapy impacts pain and quality of life in this group.

A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease